These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 1921811

  • 1. Treatment of primary hypercholesterolaemia with simvastatin. New Zealand multicentre evaluation.
    Lintott CJ, Scott RS, Sharpe DN, Nye ER, Charleson H, French JK, White HD, Reuben S, Maling TJ, Lewis GR.
    Med J Aust; 1991 Oct 07; 155(7):433-6. PubMed ID: 1921811
    [Abstract] [Full Text] [Related]

  • 2. Simvastatin versus pravastatin: efficacy and tolerability in patients with primary hypercholesterolemia.
    Malini PL, Ambrosioni E, De Divitiis O, Di Somma S, Rosiello G, Trimarco B.
    Clin Ther; 1991 Oct 07; 13(4):500-10. PubMed ID: 1934003
    [Abstract] [Full Text] [Related]

  • 3. [Effectiveness, tolerance and safety of simvastatin in comparison with bezafibrate in treatment of hypercholesterolemia].
    Lechleitner M, Sailer S, Irsigler H, Klein W, Patsch JR.
    Wien Med Wochenschr; 1995 Oct 07; 145(21):577-83. PubMed ID: 8560901
    [Abstract] [Full Text] [Related]

  • 4. A one-year multicentre study of simvastatin in the treatment of hypercholesterolaemia. UK and Eire Simvastatin Study Group.
    Br J Clin Pract; 1994 Oct 07; 48(5):231-5. PubMed ID: 7917813
    [Abstract] [Full Text] [Related]

  • 5. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia.
    Frohlich J, Brun LD, Blank D, Campeau L, Crockford P, Curnew G, Dafoe W, Davignon J, Dufour R, Emery G.
    Can J Cardiol; 1993 Jun 07; 9(5):405-12. PubMed ID: 8348392
    [Abstract] [Full Text] [Related]

  • 6. [Comparison about the efficacy and tolerability between simvastatin and bezafibrate in the treatment of hypercholesterolemia].
    Bruckert E, Truffert J, De Gennes JL.
    Ann Med Interne (Paris); 1991 Jun 07; 142(7):505-10. PubMed ID: 1789528
    [Abstract] [Full Text] [Related]

  • 7. Cholesterol-lowering therapy after heart transplantation: a 12-month randomized trial.
    Pflugfelder PW, Huff M, Oskalns R, Rudas L, Kostuk WJ.
    J Heart Lung Transplant; 1995 Jun 07; 14(4):613-22. PubMed ID: 7578166
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of medium-term treatment with simvastatin in primary hypercholesterolaemia.
    Marnini P, Colombo F, Cattaneo R, Geroli L, Venco A.
    Int J Clin Pharmacol Res; 1992 Jun 07; 12(2):65-70. PubMed ID: 1428300
    [Abstract] [Full Text] [Related]

  • 9. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov 07; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 10. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
    Strony J, Hoffman R, Hanson M, Veltri E.
    Clin Ther; 2008 Dec 07; 30(12):2280-97. PubMed ID: 19167588
    [Abstract] [Full Text] [Related]

  • 11. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
    Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.
    Clin Ther; 2008 Jan 07; 30(1):84-97. PubMed ID: 18343245
    [Abstract] [Full Text] [Related]

  • 12. Effect of combining psyllium fiber with simvastatin in lowering cholesterol.
    Moreyra AE, Wilson AC, Koraym A.
    Arch Intern Med; 2005 May 23; 165(10):1161-6. PubMed ID: 15911730
    [Abstract] [Full Text] [Related]

  • 13. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 23; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun 23; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 15. Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
    French JK, White HD, Greaves SC.
    N Z Med J; 1990 Feb 14; 103(883):41-3. PubMed ID: 2304688
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Mol MJ, Stuyt PM, Stalenhoef AF.
    Ned Tijdschr Geneeskd; 1989 Feb 18; 133(7):362-6. PubMed ID: 2927555
    [Abstract] [Full Text] [Related]

  • 17. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
    Garmendia F, Brown AS, Reiber I, Adams PC.
    Curr Med Res Opin; 2000 Feb 18; 16(3):208-19. PubMed ID: 11191012
    [Abstract] [Full Text] [Related]

  • 18. Estrogen and progestin compared with simvastatin for hypercholesterolemia in postmenopausal women.
    Darling GM, Johns JA, McCloud PI, Davis SR.
    N Engl J Med; 1997 Aug 28; 337(9):595-601. PubMed ID: 9271481
    [Abstract] [Full Text] [Related]

  • 19. Effect of ezetimibe coadministration with simvastatin in a Middle Eastern population: a prospective, multicentre, randomized, double-blind, placebo-controlled trial.
    Zubaid M, Shakir DK, Bazargani N, Binbrek A, Gopal R, Al-Tamimi O, Bakir S.
    J Cardiovasc Med (Hagerstown); 2008 Jul 28; 9(7):688-93. PubMed ID: 18545068
    [Abstract] [Full Text] [Related]

  • 20. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
    Masana L, Mata P, Gagné C, Sirah W, Cho M, Johnson-Levonas AO, Meehan A, Troxell JK, Gumbiner B, Ezetimibe Study Group.
    Clin Ther; 2005 Feb 28; 27(2):174-84. PubMed ID: 15811480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.